1. Lower dosage of aspirin promotes cell growth and osteogenic differentiation in murine bone marrow stromal cells
- Author
-
Mi Du, Wan Pan, Xiaoqi Duan, Pishan Yang, and Shaohua Ge
- Subjects
apoptosis ,aspirin ,bone marrow stromal cells ,cell cycle ,osteogenic differentiation ,proliferation ,Dentistry ,RK1-715 - Abstract
Background/purpose: The effect of aspirin on bone regeneration remains controversial. This study aimed to determine the effect of various concentrations of aspirin on cell viability, osteogenic differentiation, cell cycle, and apoptosis on ST2 cells to find an effective range of aspirin for bone regeneration induction. Materials and methods: Cell viability was measured with MTT assay after being stimulated with aspirin for 1 day, 2 days, 3 days, 5 days, and 7 days. Alkaline phosphatase (ALP) activity was measured after cells were treated for 1 day, 3 days, and 7 days. Expression of runt-related transcription factor 2 (Runx-2) was evaluated using Western-blot analysis at 3 days and 7 days. Flow cytometry was used for cell cycle and apoptosis measurement after cells were treated for 48 hours. Results: Lower concentrations of aspirin (1μΜ and 10μM) promoted cell growth and increased ALP levels and Runx-2 expression, while higher concentrations (100μΜ and 1000μΜ) inhibited cell growth (P
- Published
- 2016
- Full Text
- View/download PDF